Abstract
Provided herein are novel fused pyrazole urea analogs as glucosylceramide synthase inhibitors, pharmaceutical compositions, use of such compounds in treating diseases, particularly lysosomal storage diseases, neurodegenerative diseases, cystic diseases, and cancer, and processes for preparing such compounds.